Drugs / TAK-850
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT02367885 | Feb → May 2015 | influenza | Takeda | Completed | No outcome recorded |
| Phase 1/2 | NCT02313155 | Dec 2014 → Jan 2015 | influenza | Takeda | Completed | No outcome recorded |
| Phase 1/2 | NCT02111252 | Mar → Apr 2014 | influenza | Takeda | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT02713061 | Mar → Apr 2016 | — | Takeda | Withdrawn | No outcome recorded |
| Phase 2 | NCT02555618 | Sep → Dec 2015 | influenza | Takeda | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-850 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02367885 ↗ |
| Modality | Vaccine | “under development as a vaccine for influenza infection” NCT02367885 ↗ |
| Route | Intramuscular | “a single intramuscular injection of TAK-850” NCT02111252 ↗ |